松本 繁巳

最終更新日時: 2019/06/27 20:04:00

印刷する

氏名(漢字/フリガナ/アルファベット表記)
松本 繁巳/マツモト シゲミ/Matsumoto, Shigemi
所属部署・職名(部局/所属/講座等/職名)
医学研究科/医学専攻内科学講座腫瘍薬物治療学/准教授
学部兼担
部局 所属 講座等 職名
医学部
連絡先住所
種別 住所(日本語) 住所(英語)
職場 京都市左京区聖護院川原町54 54 Shogoinkawara-cho, Sakyo-ku, Kyoto 606-8507, Japan
連絡先電話番号
種別 番号
職場 075-751-4349
所属学会(国内)
学会名(日本語) 学会名(英語)
日本内科学会 The Japanese Society of Internal Medicine
日本癌治療学会 Japan Society of Clinical Oncology
日本臨床腫瘍学会 Japanese Society of Medical Oncology
日本消化器病学会 The Japanese Society of Gastroenterology
日本消化器内視鏡学会 Japan Gastroenterological Endoscopy Soaciety
日本医療情報学会 Japan Association for Medical Informatics
日本癌学会 Japanese Cancer Association
所属学会(海外)
学会名(英語) 国名
American Society of Clinical Oncology USA
European Society of Medical Oncology EU
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士(医学) M.D. 京都大学 Kyoto university
職歴
期間 組織名(日本語) 組織名(英語) 職名(日本語) 職名(英語)
1991/06/01〜1992/05/31 神戸大学医学部附属病院 Kobe University Hospital 内科研修医 Resident of Internal Medicine
1992/06/01〜1995/05/31 市立小野市民病院 Ono Municipal Hospital 内科医員 Clinical Fellow of Internal Medicine
1995/06/01〜1996/05/31 神戸大学医学部附属病院 Kobe University Hospital 内科医員 Clinical Fellow of 4th Internal Medicine
1996/06/01〜1999/05/31 国立がんセンター東病院 National Cancer Center Hospital East 消化器内科レジデント Resident of Gastroenterology and Endoscopy
1999/06/01〜2001/05/31 茨城県立中央病院 Ibaraki Prefectural Central Hospital 消化器内科医員 Clinical Fellow of Gastroenterology
2001/06/01〜2003/09/30 京都大学医学部附属病院 Kyoto University Hospital 消化器内科医員 Clinical Fellow of Gastroenterology and Hepatology
2003/10/01〜2007/03/31 京都大学大学院医学研究科探索臨床腫瘍学講座 Dept. of Translational Clinical Oncology, Graduate School of Medicine, Kyoto Unversity 助手 Assistant Professor
2007/04/01〜2011/03/31 京都大学大学院医学研究科探索臨床腫瘍学講座 Dept. of Translational Clinical Oncology, Graduate School of Medicine, Kyoto University 助教 Assistant Professor
2011/04/04〜2015/03/31 京都大学大学院医学研究科臨床腫瘍薬理学講座 Dept. of Clinical Oncology and Pharmacogenomics, Graduate School of Medicine, Kyoto University 特定准教授 Associate Professor
2015/04/01〜 京都大学大学院医学研究科腫瘍薬物治療学講座 Dept. of Therapeutic Oncology, Graduate School of Medicine, Kyoto University 准教授 Associate Professor
プロフィール
(日本語)
私はがん診療に携わる臨床医として、アカデミアの立場からより良い医療体制の構築に寄与したい。
(英語)
I am a medical oncologist, therefore I eager to contribute a development of the medical infrastructure based on the academic perspectives.
researchmap URL
https://researchmap.jp/7000008430
研究テーマ
(日本語)
癌化学療法の個別化治療、新規がん治療の開発、効率的な癌化学療法データベースの開発
(英語)
Precision medicine against cancer, Development of Cancer treatment database
研究概要
(日本語)
電子カルテの臨床情報を自動的に収集するシステムを開発し、我が国のがんに係るリアルワールドデータベースを構築する。さらに、ゲノム情報との統合データベース構築により我が国の癌における精密医療を促進する。
(英語)
We will develop a system to automatically collect clinical information of electronic medical records, and construct a real world database for cancer in Japan. Furthermore, we will promote precision medical care for cancer in Japan by constructing an integrated database with genomic information.
研究分野(キーワード)
キーワード(日本語) キーワード(英語)
臨床腫瘍学 Medical oncology
リアルワールドデータベース Real world database
電子カルテ EHR
精密医療 Precision medicine
クリニカルバイオバンク Clinical biobank
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Quy PN, Kanai M, Fukuyama K, Kou T, Kondo T, Yamamoto Y, Matsubara J, Hiroshima A, Mochizuki H, Sakuma T, Kamada M, Nakatsui M, Eso Y, Seno H, Masui T, Takaori K, Minamiguchi S, Matsumoto S, Muto M Quy PN, Kanai M, Fukuyama K, Kou T, Kondo T, Yamamoto Y, Matsubara J, Hiroshima A, Mochizuki H, Sakuma T, Kamada M, Nakatsui M, Eso Y, Seno H, Masui T, Takaori K, Minamiguchi S, Matsumoto S, Muto M Quy PN, Kanai M, Fukuyama K, Kou T, Kondo T, Yamamoto Y, Matsubara J, Hiroshima A, Mochizuki H, Sakuma T, Kamada M, Nakatsui M, Eso Y, Seno H, Masui T, Takaori K, Minamiguchi S, Matsumoto S, Muto M Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay. Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay. Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay. The oncologist The oncologist The oncologist 2019/06 公開
Nishino H, Hatano E, Okuno M, Toda R, Seo S, Taura K, Horimatsu T, Kanai M, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Nishino H, Hatano E, Okuno M, Toda R, Seo S, Taura K, Horimatsu T, Kanai M, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Nishino H, Hatano E, Okuno M, Toda R, Seo S, Taura K, Horimatsu T, Kanai M, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months. Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months. Clinical Practice of Postoperative Adjuvant Chemotherapy in Patients with Colorectal Liver Metastases: Impact of the Completion for Six Months. The American surgeon, 85, 2, e111-e114 The American surgeon, 85, 2, e111-e114 The American surgeon, 85, 2, e111-e114 2019/02 公開
Eso Y, Kou T, Nagai H, Kim YH, Kanai M, Matsumoto S, Mishima M, Arasawa S, Iguchi E, Nakamura F, Takeda H, Takai A, Takahashi K, Ueda Y, Muto M, Seno H Eso Y, Kou T, Nagai H, Kim YH, Kanai M, Matsumoto S, Mishima M, Arasawa S, Iguchi E, Nakamura F, Takeda H, Takai A, Takahashi K, Ueda Y, Muto M, Seno H Eso Y, Kou T, Nagai H, Kim YH, Kanai M, Matsumoto S, Mishima M, Arasawa S, Iguchi E, Nakamura F, Takeda H, Takai A, Takahashi K, Ueda Y, Muto M, Seno H Utility of ultrasound-guided liver tumor biopsy for next-generation sequencing-based clinical sequencing. Utility of ultrasound-guided liver tumor biopsy for next-generation sequencing-based clinical sequencing. Utility of ultrasound-guided liver tumor biopsy for next-generation sequencing-based clinical sequencing. Hepatology research : the official journal of the Japan Society of Hepatology Hepatology research : the official journal of the Japan Society of Hepatology Hepatology research : the official journal of the Japan Society of Hepatology 2019/01 公開
Komatsu-Fujii T, Nomura M, Otsuka A, Ishida Y, Doi K, Matsumoto S, Muto M, Kabashima K Komatsu-Fujii T, Nomura M, Otsuka A, Ishida Y, Doi K, Matsumoto S, Muto M, Kabashima K Komatsu-Fujii T, Nomura M, Otsuka A, Ishida Y, Doi K, Matsumoto S, Muto M, Kabashima K Response to imatinib in vaginal melanoma with KIT p.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab. Response to imatinib in vaginal melanoma with KIT p.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab. Response to imatinib in vaginal melanoma with KIT p.Val559Gly mutation previously treated with nivolumab, pembrolizumab and ipilimumab. The Journal of dermatology The Journal of dermatology The Journal of dermatology 2019/01 公開
Yamauchi I, Yasoda A, Matsumoto S, Sakamori Y, Kim YH, Nomura M, Otsuka A, Yamasaki T, Saito R, Kitamura M, Kitawaki T, Hishizawa M, Kawaguchi-Sakita N, Fujii T, Taura D, Sone M, Inagaki N Yamauchi I, Yasoda A, Matsumoto S, Sakamori Y, Kim YH, Nomura M, Otsuka A, Yamasaki T, Saito R, Kitamura M, Kitawaki T, Hishizawa M, Kawaguchi-Sakita N, Fujii T, Taura D, Sone M, Inagaki N Yamauchi I, Yasoda A, Matsumoto S, Sakamori Y, Kim YH, Nomura M, Otsuka A, Yamasaki T, Saito R, Kitamura M, Kitawaki T, Hishizawa M, Kawaguchi-Sakita N, Fujii T, Taura D, Sone M, Inagaki N Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab. Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab. Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab. PloS one, 14, 5, e0216954 PloS one, 14, 5, e0216954 PloS one, 14, 5, e0216954 2019 公開
Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T Shibuya H, Hijioka S, Sakamoto Y, Ito T, Ueda K, Komoto I, Kobayashi N, Kudo A, Yasuda H, Miyake H, Arita J, Kiritani S, Ikeda M, Imaoka H, Ueno M, Kobayashi S, Furuta M, Nagashio Y, Murohisa G, Aoki T, Matsumoto S, Motoya M, Azemoto N, Itakura J, Horiguchi S, Yogi T, Kawagoe T, Miyaoka Y, Imamura F, Senju M, Arioka H, Hara K, Imamura M, Okusaka T Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy. Multi-center clinical evaluation of streptozocin-based chemotherapy for advanced pancreatic neuroendocrine tumors in Japan: focus on weekly regimens and monotherapy. Cancer chemotherapy and pharmacology, 82, 4, 661-668 Cancer chemotherapy and pharmacology, 82, 4, 661-668 Cancer chemotherapy and pharmacology, 82, 4, 661-668 2018/10 公開
Goto Y, Nakamura A, Ashida R, Sakanaka K, Itasaka S, Shibuya K, Matsumoto S, Kanai M, Isoda H, Masui T, Kodama Y, Takaori K, Hiraoka M, Mizowaki T Goto Y, Nakamura A, Ashida R, Sakanaka K, Itasaka S, Shibuya K, Matsumoto S, Kanai M, Isoda H, Masui T, Kodama Y, Takaori K, Hiraoka M, Mizowaki T Goto Y, Nakamura A, Ashida R, Sakanaka K, Itasaka S, Shibuya K, Matsumoto S, Kanai M, Isoda H, Masui T, Kodama Y, Takaori K, Hiraoka M, Mizowaki T Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer. Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer. Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer. Radiation oncology (London, England), 13, 1, 118 Radiation oncology (London, England), 13, 1, 118 Radiation oncology (London, England), 13, 1, 118 2018/06 公開
Goto Y, Ashida R, Nakamura A, Itasaka S, Shibuya K, Akimoto M, Mukumoto N, Matsumoto S, Kanai M, Isoda H, Masui T, Kodama Y, Nakamura M, Takaori K, Mizowaki T, Hiraoka M Goto Y, Ashida R, Nakamura A, Itasaka S, Shibuya K, Akimoto M, Mukumoto N, Matsumoto S, Kanai M, Isoda H, Masui T, Kodama Y, Nakamura M, Takaori K, Mizowaki T, Hiraoka M Goto Y, Ashida R, Nakamura A, Itasaka S, Shibuya K, Akimoto M, Mukumoto N, Matsumoto S, Kanai M, Isoda H, Masui T, Kodama Y, Nakamura M, Takaori K, Mizowaki T, Hiraoka M Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac. Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac. Clinical results of dynamic tumor tracking intensity-modulated radiotherapy with real-time monitoring for pancreatic cancers using a gimbal mounted linac. Oncotarget, 9, 34, 23628-23635 Oncotarget, 9, 34, 23628-23635 Oncotarget, 9, 34, 23628-23635 2018/05 公開
Kou T, Kanai M, Kamada M, Nakatsui M, Matsumoto S, Okuno Y, Muto M Kou T, Kanai M, Kamada M, Nakatsui M, Matsumoto S, Okuno Y, Muto M Kou T, Kanai M, Kamada M, Nakatsui M, Matsumoto S, Okuno Y, Muto M A Platform for Comprehensive Genomic Profiling in Human Cancers and Pharmacogenomics Therapy Selection. A Platform for Comprehensive Genomic Profiling in Human Cancers and Pharmacogenomics Therapy Selection. A Platform for Comprehensive Genomic Profiling in Human Cancers and Pharmacogenomics Therapy Selection. Methods in molecular biology (Clifton, N.J.), 1825, 413-424 Methods in molecular biology (Clifton, N.J.), 1825, 413-424 Methods in molecular biology (Clifton, N.J.), 1825, 413-424 2018 公開
Setoyama T, Miyamoto SI, Nikaido M, Horimatsu T, Matsumoto S, Ezoe Y, Morita S, Aoyama I, Kawanami C, Kusaka T, Chiba T, Muto M, Seno H Setoyama T, Miyamoto SI, Nikaido M, Horimatsu T, Matsumoto S, Ezoe Y, Morita S, Aoyama I, Kawanami C, Kusaka T, Chiba T, Muto M, Seno H Setoyama T, Miyamoto SI, Nikaido M, Horimatsu T, Matsumoto S, Ezoe Y, Morita S, Aoyama I, Kawanami C, Kusaka T, Chiba T, Muto M, Seno H [Evaluation of the safety and efficacy of endoscopic treatment for early gastric cancers in patients aged over 80 years]. [Evaluation of the safety and efficacy of endoscopic treatment for early gastric cancers in patients aged over 80 years]. [Evaluation of the safety and efficacy of endoscopic treatment for early gastric cancers in patients aged over 80 years]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 115, 5, 467-475 Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 115, 5, 467-475 Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 115, 5, 467-475 2018 公開
Yamamoto H, Toyooka S, Ninomiya T, Matsumoto S, Kanai M, Tomida S, Kiura K, Muto M, Suzawa K, Desmeules P, Kris MG, Li BT, Ladanyi M Yamamoto H, Toyooka S, Ninomiya T, Matsumoto S, Kanai M, Tomida S, Kiura K, Muto M, Suzawa K, Desmeules P, Kris MG, Li BT, Ladanyi M Yamamoto H, Toyooka S, Ninomiya T, Matsumoto S, Kanai M, Tomida S, Kiura K, Muto M, Suzawa K, Desmeules P, Kris MG, Li BT, Ladanyi M Therapeutic Potential of Afatinib for Cancers with <i>ERBB2</i> (<i>HER2</i>) Transmembrane Domain Mutations G660D and V659E. Therapeutic Potential of Afatinib for Cancers with <i>ERBB2</i> (<i>HER2</i>) Transmembrane Domain Mutations G660D and V659E. Therapeutic Potential of Afatinib for Cancers with <i>ERBB2</i> (<i>HER2</i>) Transmembrane Domain Mutations G660D and V659E. The oncologist The oncologist The oncologist 2017/11 公開
Nomura M, Otsuka A, Kondo T, Nagai H, Nonomura Y, Kaku Y, Matsumoto S, Muto M Nomura M, Otsuka A, Kondo T, Nagai H, Nonomura Y, Kaku Y, Matsumoto S, Muto M Nomura M, Otsuka A, Kondo T, Nagai H, Nonomura Y, Kaku Y, Matsumoto S, Muto M Efficacy and safety of retreatment with nivolumab in metastatic melanoma patients previously treated with nivolumab. Efficacy and safety of retreatment with nivolumab in metastatic melanoma patients previously treated with nivolumab. Efficacy and safety of retreatment with nivolumab in metastatic melanoma patients previously treated with nivolumab. Cancer chemotherapy and pharmacology, 80, 5, 999-1004 Cancer chemotherapy and pharmacology, 80, 5, 999-1004 Cancer chemotherapy and pharmacology, 80, 5, 999-1004 2017/11 公開
Xue P, Hang J, Huang W, Li S, Li N, Kodama Y, Matsumoto S, Takaori K, Zhu L, Kanai M Xue P, Hang J, Huang W, Li S, Li N, Kodama Y, Matsumoto S, Takaori K, Zhu L, Kanai M Xue P, Hang J, Huang W, Li S, Li N, Kodama Y, Matsumoto S, Takaori K, Zhu L, Kanai M Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort Study of 2 Countries. Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort Study of 2 Countries. Validation of Lymphocyte-to-Monocyte Ratio as a Prognostic Factor in Advanced Pancreatic Cancer: An East Asian Cohort Study of 2 Countries. Pancreas, 46, 8, 1011-1017 Pancreas, 46, 8, 1011-1017 Pancreas, 46, 8, 1011-1017 2017/09 公開
Kou T, Kanai M, Yamamoto Y, Kamada M, Nakatsui M, Sakuma T, Mochizuki H, Hiroshima A, Sugiyama A, Nakamura E, Miyake H, Minamiguchi S, Takaori K, Matsumoto S, Haga H, Seno H, Kosugi S, Okuno Y, Muto M Kou T, Kanai M, Yamamoto Y, Kamada M, Nakatsui M, Sakuma T, Mochizuki H, Hiroshima A, Sugiyama A, Nakamura E, Miyake H, Minamiguchi S, Takaori K, Matsumoto S, Haga H, Seno H, Kosugi S, Okuno Y, Muto M Kou T, Kanai M, Yamamoto Y, Kamada M, Nakatsui M, Sakuma T, Mochizuki H, Hiroshima A, Sugiyama A, Nakamura E, Miyake H, Minamiguchi S, Takaori K, Matsumoto S, Haga H, Seno H, Kosugi S, Okuno Y, Muto M Clinical Sequencing Using a Next-Generation Sequencing-Based Multiplex Gene Assay in Patients with Advanced Solid Tumors. Clinical Sequencing Using a Next-Generation Sequencing-Based Multiplex Gene Assay in Patients with Advanced Solid Tumors. Clinical Sequencing Using a Next-Generation Sequencing-Based Multiplex Gene Assay in Patients with Advanced Solid Tumors. Cancer science Cancer science Cancer science 2017/04 英語 公開
Uneno Y, Taneishi K, Kanai M, Okamoto K, Yamamoto Y, Yoshioka A, Hiramoto S, Nozaki A, Nishikawa Y, Yamaguchi D, Tomono T, Nakatsui M, Baba M, Morita T, Matsumoto S, Kuroda T, Okuno Y, Muto M Uneno Y, Taneishi K, Kanai M, Okamoto K, Yamamoto Y, Yoshioka A, Hiramoto S, Nozaki A, Nishikawa Y, Yamaguchi D, Tomono T, Nakatsui M, Baba M, Morita T, Matsumoto S, Kuroda T, Okuno Y, Muto M Uneno Y, Taneishi K, Kanai M, Okamoto K, Yamamoto Y, Yoshioka A, Hiramoto S, Nozaki A, Nishikawa Y, Yamaguchi D, Tomono T, Nakatsui M, Baba M, Morita T, Matsumoto S, Kuroda T, Okuno Y, Muto M Development and validation of a set of six adaptable prognosis prediction (SAP) models based on time-series real-world big data analysis for patients with cancer receiving chemotherapy: A multicenter case crossover study. Development and validation of a set of six adaptable prognosis prediction (SAP) models based on time-series real-world big data analysis for patients with cancer receiving chemotherapy: A multicenter case crossover study. Development and validation of a set of six adaptable prognosis prediction (SAP) models based on time-series real-world big data analysis for patients with cancer receiving chemotherapy: A multicenter case crossover study. PloS one, 12, 8, e0183291 PloS one, 12, 8, e0183291 PloS one, 12, 8, e0183291 2017 公開
松本 繁巳、髙忠之、金井雅史、武藤学 松本 繁巳、髙忠之、金井雅史、武藤学 Shigemi Matsumoto がん治療におけるPrecision Medicine実践 がん治療におけるPrecision Medicine実践 Recent challenges and perspectives in cancer precision medicine 腫瘍内科, 20, 6, 628-645 腫瘍内科, 20, 6, 628-645 , 20, 6, 628-645 2017 日本語 公開
Nishikawa Y, Kanai M, Narahara M, Tamon A, Brown JB, Taneishi K, Nakatsui M, Okamoto K, Uneno Y, Yamaguchi D, Tomono T, Mori Y, Matsumoto S, Okuno Y, Muto M Nishikawa Y, Kanai M, Narahara M, Tamon A, Brown JB, Taneishi K, Nakatsui M, Okamoto K, Uneno Y, Yamaguchi D, Tomono T, Mori Y, Matsumoto S, Okuno Y, Muto M Nishikawa Y, Kanai M, Narahara M, Tamon A, Brown JB, Taneishi K, Nakatsui M, Okamoto K, Uneno Y, Yamaguchi D, Tomono T, Mori Y, Matsumoto S, Okuno Y, Muto M Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population. Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population. Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population. International journal of clinical oncology International journal of clinical oncology International journal of clinical oncology 2016/11 公開
Nagayama S, Hasegawa S, Hida K, Kawada K, Hatano E, Nakamura K, Seo S, Taura K, Yasuchika K, Matsuo T, Zaima M, Kanazawa A, Terajima H, Tada M, Adachi Y, Nishitai R, Manaka D, Yoshimura T, Doi K, Horimatsu T, Mitsuyoshi A, Yoshimura K, Niimi M, Matsumoto S, Sakai Y, Uemoto S Nagayama S, Hasegawa S, Hida K, Kawada K, Hatano E, Nakamura K, Seo S, Taura K, Yasuchika K, Matsuo T, Zaima M, Kanazawa A, Terajima H, Tada M, Adachi Y, Nishitai R, Manaka D, Yoshimura T, Doi K, Horimatsu T, Mitsuyoshi A, Yoshimura K, Niimi M, Matsumoto S, Sakai Y, Uemoto S Nagayama S, Hasegawa S, Hida K, Kawada K, Hatano E, Nakamura K, Seo S, Taura K, Yasuchika K, Matsuo T, Zaima M, Kanazawa A, Terajima H, Tada M, Adachi Y, Nishitai R, Manaka D, Yoshimura T, Doi K, Horimatsu T, Mitsuyoshi A, Yoshimura K, Niimi M, Matsumoto S, Sakai Y, Uemoto S Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers. Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers. Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers. International journal of clinical oncology International journal of clinical oncology International journal of clinical oncology 2016/10 公開
Yamamura K, Otsuka A, Kaku Y, Seidel JA, Nomura M, Nagai H, Matsumoto S, Kabashima K Yamamura K, Otsuka A, Kaku Y, Seidel JA, Nomura M, Nagai H, Matsumoto S, Kabashima K Yamamura K, Otsuka A, Kaku Y, Seidel JA, Nomura M, Nagai H, Matsumoto S, Kabashima K Dermoscopic changes in malignant melanoma after successful treatment with nivolumab: A case report. Dermoscopic changes in malignant melanoma after successful treatment with nivolumab: A case report. Dermoscopic changes in malignant melanoma after successful treatment with nivolumab: A case report. The Journal of dermatology The Journal of dermatology The Journal of dermatology 2016/07 公開
Kou T, Kanai M, Matsumoto S, Okuno Y, Muto M Kou T, Kanai M, Matsumoto S, Okuno Y, Muto M Kou T, Kanai M, Matsumoto S, Okuno Y, Muto M The possibility of clinical sequencing in the management of cancer. The possibility of clinical sequencing in the management of cancer. The possibility of clinical sequencing in the management of cancer. Japanese journal of clinical oncology, 46, 5, 399-406 Japanese journal of clinical oncology, 46, 5, 399-406 Japanese journal of clinical oncology, 46, 5, 399-406 2016/05 公開
Hironaka S, Sugimoto N, Yamaguchi K, Moriwaki T, Komatsu Y, Nishina T, Tsuji A, Nakajima TE, Gotoh M, Machida N, Bando H, Esaki T, Emi Y, Sekikawa T, Matsumoto S, Takeuchi M, Boku N, Baba H, Hyodo I Hironaka S, Sugimoto N, Yamaguchi K, Moriwaki T, Komatsu Y, Nishina T, Tsuji A, Nakajima TE, Gotoh M, Machida N, Bando H, Esaki T, Emi Y, Sekikawa T, Matsumoto S, Takeuchi M, Boku N, Baba H, Hyodo I Hironaka S, Sugimoto N, Yamaguchi K, Moriwaki T, Komatsu Y, Nishina T, Tsuji A, Nakajima TE, Gotoh M, Machida N, Bando H, Esaki T, Emi Y, Sekikawa T, Matsumoto S, Takeuchi M, Boku N, Baba H, Hyodo I S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial. S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial. S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial. The Lancet. Oncology, 17, 1, 99-108 The Lancet. Oncology, 17, 1, 99-108 The Lancet. Oncology, 17, 1, 99-108 2016/01 公開
Uneno Y, Yokoyama A, Nishikawa Y, Funakoshi T, Ozaki Y, Aoyama I, Baba K, Yamaguchi D, Morita S, Mori Y, Kanai M, Kinoshita H, Inoue T, Sawamoto N, Matsumoto R, Matsumoto S, Muto M Uneno Y, Yokoyama A, Nishikawa Y, Funakoshi T, Ozaki Y, Aoyama I, Baba K, Yamaguchi D, Morita S, Mori Y, Kanai M, Kinoshita H, Inoue T, Sawamoto N, Matsumoto R, Matsumoto S, Muto M Uneno Y, Yokoyama A, Nishikawa Y, Funakoshi T, Ozaki Y, Aoyama I, Baba K, Yamaguchi D, Morita S, Mori Y, Kanai M, Kinoshita H, Inoue T, Sawamoto N, Matsumoto R, Matsumoto S, Muto M Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review. Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review. Paraneoplastic Limbic Encephalitis in a Human Epidermal Growth Factor Receptor-2-positive Gastric Cancer Patient Treated with Trastuzumab-combined Chemotherapy: A Case Report and Literature Review. Internal medicine (Tokyo, Japan), 55, 18, 2605-2609 Internal medicine (Tokyo, Japan), 55, 18, 2605-2609 Internal medicine (Tokyo, Japan), 55, 18, 2605-2609 2016 公開
金井雅史、髙忠之、松本繁巳、武藤学、児玉裕三、増井俊彦、高折恭一、南口早智子、鎌田真由美、中津井雅彦、奥野恭史、佐久間朋寛、望月洋明、広島明宣 金井雅史、髙忠之、松本繁巳、武藤学、児玉裕三、増井俊彦、高折恭一、南口早智子、鎌田真由美、中津井雅彦、奥野恭史、佐久間朋寛、望月洋明、広島明宣 網羅的癌関連遺伝子変異検査(OncoPrime)による膵癌ゲノム異常解析と治療への応用 網羅的癌関連遺伝子変異検査(OncoPrime)による膵癌ゲノム異常解析と治療への応用 Clinical application of panel-based comprehensive clinical sequencing(OncoPrime) for patients with pancreatic cancer 端と膵, 37, 9, 791-795 端と膵, 37, 9, 791-795 , 37, 9, 791-795 2016 日本語 公開
Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer. Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer. Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33, 34, 4015-4022 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33, 34, 4015-4022 Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33, 34, 4015-4022 2015/12 公開
Kishi T, Nakamura A, Itasaka S, Shibuya K, Matsumoto S, Kanai M, Kodama Y, Takaori K, Mizowaki T, Hiraoka M Kishi T, Nakamura A, Itasaka S, Shibuya K, Matsumoto S, Kanai M, Kodama Y, Takaori K, Mizowaki T, Hiraoka M Kishi T, Nakamura A, Itasaka S, Shibuya K, Matsumoto S, Kanai M, Kodama Y, Takaori K, Mizowaki T, Hiraoka M Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Pretreatment C-reactive protein level predicts outcome and patterns of failure after chemoradiotherapy for locally advanced pancreatic cancer. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 15, 6, 694-700 Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 15, 6, 694-700 Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 15, 6, 694-700 2015/11 公開
Mori Y, Nagayama S, Kawamura JI, Hasegawa S, Tanaka E, Okabe H, Takeuchi M, Sonobe M, Matsumoto S, Kanai M, Muto M, Chiba T, Sakai Y Mori Y, Nagayama S, Kawamura JI, Hasegawa S, Tanaka E, Okabe H, Takeuchi M, Sonobe M, Matsumoto S, Kanai M, Muto M, Chiba T, Sakai Y Mori Y, Nagayama S, Kawamura JI, Hasegawa S, Tanaka E, Okabe H, Takeuchi M, Sonobe M, Matsumoto S, Kanai M, Muto M, Chiba T, Sakai Y A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute. International journal of clinical oncology, 21, 3, 474-482 International journal of clinical oncology, 21, 3, 474-482 International journal of clinical oncology, 21, 3, 474-482 2015/10 公開
Okuno M, Hatano E, Kasai Y, Nishio T, Seo S, Taura K, Yasuchika K, Nitta T, Mori A, Okajima H, Kaido T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Okuno M, Hatano E, Kasai Y, Nishio T, Seo S, Taura K, Yasuchika K, Nitta T, Mori A, Okajima H, Kaido T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Okuno M, Hatano E, Kasai Y, Nishio T, Seo S, Taura K, Yasuchika K, Nitta T, Mori A, Okajima H, Kaido T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases. Feasibility of the liver-first approach for patients with initially unresectable and not optimally resectable synchronous colorectal liver metastases. Surgery today Surgery today Surgery today 2015/08 公開
Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T Kou T, Kanai M, Yamamoto M, Xue P, Mori Y, Kudo Y, Kurita A, Uza N, Kodama Y, Asada M, Kawaguchi M, Masui T, Mizumoto M, Yazumi S, Matsumoto S, Takaori K, Morita S, Muto M, Uemoto S, Chiba T Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy. International journal of clinical oncology International journal of clinical oncology International journal of clinical oncology 2015/06 公開
Hatano E, Okuno M, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Hatano E, Okuno M, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Hatano E, Okuno M, Nakamura K, Ishii T, Seo S, Taura K, Yasuchika K, Yazawa T, Zaima M, Kanazawa A, Terajima H, Kaihara S, Adachi Y, Inoue N, Furumoto K, Manaka D, Tokka A, Furuyama H, Doi K, Hirose T, Horimatsu T, Hasegawa S, Matsumoto S, Sakai Y, Uemoto S Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study). Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study). Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study). Journal of hepato-biliary-pancreatic sciences Journal of hepato-biliary-pancreatic sciences Journal of hepato-biliary-pancreatic sciences 2015/04 公開
Matsumoto T, Hasegawa S, Matsumoto S, Horimatsu T, Okoshi K, Yamada M, Kawada K, Sakai Y Matsumoto T, Hasegawa S, Matsumoto S, Horimatsu T, Okoshi K, Yamada M, Kawada K, Sakai Y Matsumoto T, Hasegawa S, Matsumoto S, Horimatsu T, Okoshi K, Yamada M, Kawada K, Sakai Y Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor. Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor. Diseases of the colon and rectum, 57, 6, 679-686 Diseases of the colon and rectum, 57, 6, 679-686 Diseases of the colon and rectum, 57, 6, 679-686 2014/06 公開
Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy. Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy. Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy. Pancreas, 43, 3, 411-416 Pancreas, 43, 3, 411-416 Pancreas, 43, 3, 411-416 2014/04 公開
Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T Xue P, Kanai M, Mori Y, Nishimura T, Uza N, Kodama Y, Kawaguchi Y, Takaori K, Matsumoto S, Uemoto S, Chiba T Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients. Cancer medicine, 3, 2, 406-415 Cancer medicine, 3, 2, 406-415 Cancer medicine, 3, 2, 406-415 2014/04 公開
Nagai H, Kitano T, Nishimura T, Yasuda H, Nakata K, Takashima S, Kanai M, Matsumoto S, Mori Y, Kakudo Y, Sato H, Yamaguchi T, Kameno K, Kim YH, Mishima M, Yanagihara K Nagai H, Kitano T, Nishimura T, Yasuda H, Nakata K, Takashima S, Kanai M, Matsumoto S, Mori Y, Kakudo Y, Sato H, Yamaguchi T, Kameno K, Kim YH, Mishima M, Yanagihara K H. Nagai; T. Kitano; T. Nishimura; H. Yasuda; K. Nakata; S. Takashima; M. Kanai; S. Matsumoto; Y. Mori; Y. Kakudo; H. Sato; T. Yamaguchi; K. Kameno; Y.H. Kim; M. Mishima; K. Yanagihara Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study. Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study. Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: A double-blind randomized crossover study Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 21, 12, 3271-3278 Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 21, 12, 3271-3278 Supportive Care in Cancer, 21, 12, 3271-3278 2013/12 英語 公開
松本 繁巳 松本 繁巳 松本 繁巳 外来通院センターからみた医療経済学 : 入院治療との比較 (特集 大腸癌治療の医療経済学) 外来通院センターからみた医療経済学 : 入院治療との比較 (特集 大腸癌治療の医療経済学) Comparison of medicalcosts between inpatient and outpatient setting 大腸癌frontier, 4, 4, 363-369 大腸癌frontier, 4, 4, 363-369 大腸癌frontier, 4, 4, 363-369 2011/12 日本語 公開
松本 繁巳 松本 繁巳 ゼローダ+CDDP(XP)療法 (特集 やりなおしの消化器がん化学療法のケアカレンダー式レジメンでらくらく理解) -- (胃がん) ゼローダ+CDDP(XP)療法 (特集 やりなおしの消化器がん化学療法のケアカレンダー式レジメンでらくらく理解) -- (胃がん) 消化器外科nursing, 16, 7, 662-666 消化器外科nursing, 16, 7, 662-666 , 16, 7, 662-666 2011/07 日本語 公開
松本 繁巳 松本 繁巳 S-1+CDDP療法 (特集 やりなおしの消化器がん化学療法のケアカレンダー式レジメンでらくらく理解) -- (胃がん) S-1+CDDP療法 (特集 やりなおしの消化器がん化学療法のケアカレンダー式レジメンでらくらく理解) -- (胃がん) 消化器外科nursing, 16, 7, 657-661 消化器外科nursing, 16, 7, 657-661 , 16, 7, 657-661 2011/07 日本語 公開
松本 繁巳 松本 繁巳 ゼローダ+CDDP+ハーセプチン(XPH)療法 (特集 やりなおしの消化器がん化学療法のケアカレンダー式レジメンでらくらく理解) -- (胃がん) ゼローダ+CDDP+ハーセプチン(XPH)療法 (特集 やりなおしの消化器がん化学療法のケアカレンダー式レジメンでらくらく理解) -- (胃がん) 消化器外科nursing, 16, 7, 667-672 消化器外科nursing, 16, 7, 667-672 , 16, 7, 667-672 2011/07 日本語 公開
Alaboudy A, Elbahrawy A, Matsumoto S, Galal GM, Chiba T Alaboudy A, Elbahrawy A, Matsumoto S, Galal GM, Chiba T Alaboudy A, Elbahrawy A, Matsumoto S, Galal GM, Chiba T Regular arrangement of collecting venules: Does patient age affect its accuracy? Regular arrangement of collecting venules: Does patient age affect its accuracy? Regular arrangement of collecting venules: Does patient age affect its accuracy? World journal of gastrointestinal endoscopy, 3, 6, 118-123 World journal of gastrointestinal endoscopy, 3, 6, 118-123 World journal of gastrointestinal endoscopy, 3, 6, 118-123 2011/06 公開
Yanagihara K, Yoshimura K, Niimi M, Yasuda H, Sasaki T, Nishimura T, Ishiguro H, Matsumoto S, Kitano T, Kanai M, Misawa A, Tada H, Teramukai S, Mio T, Fukushima M Yanagihara K, Yoshimura K, Niimi M, Yasuda H, Sasaki T, Nishimura T, Ishiguro H, Matsumoto S, Kitano T, Kanai M, Misawa A, Tada H, Teramukai S, Mio T, Fukushima M K. Yanagihara; K. Yoshimura; M. Niimi; H. Yasuda; T. Sasaki; T. Nishimura; H. Ishiguro; S. Matsumoto; T. Kitano; M. Kanai; A. Misawa; H. Tada; S. Teramukai; T. Mio; M. Fukushima Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer. Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer. Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer Cancer chemotherapy and pharmacology, 66, 5, 913-918 Cancer chemotherapy and pharmacology, 66, 5, 913-918 Cancer Chemotherapy and Pharmacology, 66, 5, 913-918 2010/10 英語 公開
, , , , MINAMI Manabu, MATSUMOTO Shigemi, HORIUCHI Hisanori Cardiovascular Side-Effects of Modern Cancer Therapy Cardiovascular Side-Effects of Modern Cancer Therapy Cardiovascular Side-Effects of Modern Cancer Therapy Circulation journal : official journal of the Japanese Circulation Society, 74, 9, 1779-1786 Circulation journal : official journal of the Japanese Circulation Society, 74, 9, 1779-1786 JAPANESE CIRCULATION JOURNAL, 74, 9, 1779-1786 2010/08/25 英語 公開
Okuchi Y, Nagayama S, Mori Y, Kawamura J, Matsumoto S, Nishimura T, Yoshizawa A, Sakai Y Okuchi Y, Nagayama S, Mori Y, Kawamura J, Matsumoto S, Nishimura T, Yoshizawa A, Sakai Y Y. Okuchi; S. Nagayama; Y. Mori; J. Kawamura; S. Matsumoto; T. Nishimura; A. Yoshizawa; Y. Sakai VEGF hypersecretion as a plausible mechanism for pseudo-meigs' syndrome in advanced colorectal cancer. VEGF hypersecretion as a plausible mechanism for pseudo-meigs' syndrome in advanced colorectal cancer. VEGF hypersecretion as a plausible mechanism for pseudo-meigs\\' syndrome in advanced colorectal cancer Japanese journal of clinical oncology, 40, 5, 476-481 Japanese journal of clinical oncology, 40, 5, 476-481 Japanese Journal of Clinical Oncology, 40, 5, 476-481 2010/05 英語 公開
Mori Y, Nishimura T, Kitano T, Yoshimura K, Matsumoto S, Kanai M, Hazama M, Ishiguro H, Nagayama S, Yanagihara K, Teramukai S, Chiba T, Sakai Y, Fukushima M Mori Y, Nishimura T, Kitano T, Yoshimura K, Matsumoto S, Kanai M, Hazama M, Ishiguro H, Nagayama S, Yanagihara K, Teramukai S, Chiba T, Sakai Y, Fukushima M Y. Mori; T. Nishimura; T. Kitano; K.-I. Yoshimura; S. Matsumoto; M. Kanai; M. Hazama; H. Ishiguro; S. Nagayama; K. Yanagihara; S. Teramukai; T. Chiba; Y. Sakai; M. Fukushima Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX. Oxaliplatin-free interval as a risk factor for hypersensitivity reaction among colorectal cancer patients treated with FOLFOX Oncology, 79, 1-2, 136-143 Oncology, 79, 1-2, 136-143 Oncology, 79, 1-2, 136-143 2010 英語 公開
山本 景一, 松本 繁巳, 柳原 一広 山本 景一, 松本 繁巳, 柳原 一広 電子カルテシステムと臨床研究の連携--現状と実現のための要件 (特集 電子カルテCutting Edge) 電子カルテシステムと臨床研究の連携--現状と実現のための要件 (特集 電子カルテCutting Edge) 映像情報medical, 41, 5, 505-510 映像情報medical, 41, 5, 505-510 , 41, 5, 505-510 2009/05 日本語 公開
ONOUE Masahide, TERADA Tomohiro, KOBAYASHI Masahiko, KATSURA Toshiya, MATSUMOTO Shigemi, YANAGIHARA Kazuhiro, NISHIMURA Takafumi, KANAI Masashi, TERAMUKAI Satoshi, SHIMIZU Akira, FUKUSHIMA Masanori, INUI Ken-ichi ONOUE Masahide, TERADA Tomohiro, KOBAYASHI Masahiko, KATSURA Toshiya, MATSUMOTO Shigemi, YANAGIHARA Kazuhiro, NISHIMURA Takafumi, KANAI Masashi, TERAMUKAI Satoshi, SHIMIZU Akira, FUKUSHIMA Masanori, INUI Ken-ichi ONOUE Masahide, TERADA Tomohiro, KOBAYASHI Masahiko, KATSURA Toshiya, MATSUMOTO Shigemi, YANAGIHARA Kazuhiro, NISHIMURA Takafumi, KANAI Masashi, TERAMUKAI Satoshi, SHIMIZU Akira, FUKUSHIMA Masanori, INUI Ken-ichi UGT1A1^*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients UGT1A1^*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients UGT1A1^*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology, 14, 2, 136-142 International journal of clinical oncology : official journal of the Japan Society of Clinical Oncology, 14, 2, 136-142 Int J Clin Oncol, 14, 2, 136-142 2009/04/01 英語 公開
祝 千佳子, 小林 政彦, 寺田 智祐, 矢野 育子, 松本 繁巳, 柳原 一広, 福島 雅典, 乾 賢一 祝 千佳子, 小林 政彦, 寺田 智祐, 矢野 育子, 松本 繁巳, 柳原 一広, 福島 雅典, 乾 賢一 Iwai Chikako, Kobayashi Masahiko, Terada Tomohiro, Yano Ikuko, Matumoto Shigemi, Yanagihara Kazuhiro, Fukushima Masanori, Inui Ken-ichi 外来化学療法部におけるTS‐1服用患者に対する継続的な薬学的管理―患者教育システムの構築と積極的なファーマシューティカルケアヘの取り組み―:-患者教育システムの構築と積極的なファーマシューティカルケアへの取り組み- 外来化学療法部におけるTS‐1服用患者に対する継続的な薬学的管理―患者教育システムの構築と積極的なファーマシューティカルケアヘの取り組み―:-患者教育システムの構築と積極的なファーマシューティカルケアへの取り組み- Continuous Pharmaceutical Consultation Regarding Chemotherapy Combined with TS-1 in Outpatient Oncology Unit: Establishment of Patient Education System and Active Provision of Pharmaceutical Care:Establishment of Patient Education System and Active Provis 医療薬学, 35, 12, 866-874 医療薬学, 35, 12, 866-874 Japanese Journal of Hospital Pharmacy, 35, 12, 866-874 2009 日本語 公開
松本 繁巳 松本 繁巳 胃癌治療法--現状・動向・評価 併用療法 CPT-11との併用療法 CPT-11+CDDP (胃癌--基礎・臨床研究のアップデート) -- (治療--現状・動向・評価) 胃癌治療法--現状・動向・評価 併用療法 CPT-11との併用療法 CPT-11+CDDP (胃癌--基礎・臨床研究のアップデート) -- (治療--現状・動向・評価) 日本臨床, 66, 0, 395-399 日本臨床, 66, 0, 395-399 , 66, 0, 395-399 2008/07 日本語 公開
Yamauchi J, Kanai M, Matsumoto S, Nishimura T, Yazumi S, Kami K, Kawaguchi Y, Yasuda H, Kitano T, Misawa A, Ishiguro H, Yoshikawa K, Yanagihara K, Fukushima M, Doi R, Chiba T Yamauchi J, Kanai M, Matsumoto S, Nishimura T, Yazumi S, Kami K, Kawaguchi Y, Yasuda H, Kitano T, Misawa A, Ishiguro H, Yoshikawa K, Yanagihara K, Fukushima M, Doi R, Chiba T J. Yamauchi; M. Kanai; S. Matsumoto; T. Nishimura; S. Yazumi; K. Kami; Y. Kawaguchi; H. Yasuda; T. Kitano; A. Misawa; H. Ishiguro; K. Yoshikawa; K. Yanagihara; M. Fukushima; R. Doi; T. Chiba Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer Pancreas, 36, 3, 327-328 Pancreas, 36, 3, 327-328 Pancreas, 36, 3, 327-328 2008/04 英語 公開
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M T. Yamanaka; S. Matsumoto; S. Teramukai; R. Ishiwata; Y. Nagai; M. Fukushima Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients. Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: analysis of 3,758 patients. Safety evaluation of oral fluoropyrimidine S-1 for short- and long-term delivery in advanced gastric cancer: Analysis of 3,758 patients Cancer chemotherapy and pharmacology, 61, 2, 335-343 Cancer chemotherapy and pharmacology, 61, 2, 335-343 Cancer Chemotherapy and Pharmacology, 61, 2, 335-343 2008/02 英語 公開
Matsumoto S, Nishimura T, Kanai M, Mori Y, Nagayama S, Kawamura J, Nomura A, Miyamoto S, Kitano T, Ishiguro H, Yanagihara K, Teramukai S, Sakai Y, Chiba T, Fukushima M Matsumoto S, Nishimura T, Kanai M, Mori Y, Nagayama S, Kawamura J, Nomura A, Miyamoto S, Kitano T, Ishiguro H, Yanagihara K, Teramukai S, Sakai Y, Chiba T, Fukushima M S. Matsumoto; T. Nishimura; M. Kanai; Y. Mori; S. Nagayama; J. Kawamura; A. Nomura; S. Miyamoto; T. Kitano; H. Ishiguro; K. Yanagihara; S. Teramukai; Y. Sakai; T. Chiba; M. Fukushima Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer. A single-institution outcome study. Safety and efficacy of modified FOLFOX6 for treatment of metastatic or locally advanced colorectal cancer: A single-institution outcome study Chemotherapy, 54, 5, 395-403 Chemotherapy, 54, 5, 395-403 Chemotherapy, 54, 5, 395-403 2008 英語 公開
赤澤 麻衣子, 橋田 亨, 矢野 育子, 桂 敏也, 高島 幸恵, 手良向 聡, 松本 繁巳, 柳原 一広, 福島 雅典, 乾 賢一 赤澤 麻衣子, 橋田 亨, 矢野 育子, 桂 敏也, 高島 幸恵, 手良向 聡, 松本 繁巳, 柳原 一広, 福島 雅典, 乾 賢一 Akazawa Maiko, Hashida Tohru, Yano Ikuko, Katsura Toshiya, Takashima Sachie, Teramukai Satoshi, Matsumoto Shigemi, Yanagihara Kazuhiro, Fukushima Masanori, Inui Ken-ichi がん化学療法による悪心・嘔吐発現の性差 がん化学療法による悪心・嘔吐発現の性差 Gender Differences in Chemotherapy-induced Nausea and Vomiting 医療薬学, 34, 8, 742-747 医療薬学, 34, 8, 742-747 Japanese Journal of Hospital Pharmacy, 34, 8, 742-747 2008 日本語 公開
Kitano T, Tada H, Nishimura T, Teramukai S, Kanai M, Nishimura T, Misawa A, Yoshikawa K, Yasuda H, Ishiguro H, Matsumoto S, Yanagihara K, Fukushima M Kitano T, Tada H, Nishimura T, Teramukai S, Kanai M, Nishimura T, Misawa A, Yoshikawa K, Yasuda H, Ishiguro H, Matsumoto S, Yanagihara K, Fukushima M T. Kitano; H. Tada; T. Nishimura; S. Teramukai; M. Kanai; T. Nishimura; A. Misawa; K. Yoshikawa; H. Yasuda; H. Ishiguro; S. Matsumoto; K. Yanagihara; M. Fukushima Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy. Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy. Prevalence and incidence of anemia in Japanese cancer patients receiving outpatient chemotherapy International journal of hematology, 86, 1, 37-41 International journal of hematology, 86, 1, 37-41 International Journal of Hematology, 86, 1, 37-41 2007/07 英語 公開
Kanai M, Matsumoto S, Nishimura T, Shimada Y, Watanabe G, Kitano T, Misawa A, Ishiguro H, Yoshikawa K, Yanagihara K, Teramukai S, Mitsumori M, Chiba T, Sakai Y, Fukushima M Kanai M, Matsumoto S, Nishimura T, Shimada Y, Watanabe G, Kitano T, Misawa A, Ishiguro H, Yoshikawa K, Yanagihara K, Teramukai S, Mitsumori M, Chiba T, Sakai Y, Fukushima M M. Kanai; S. Matsumoto; T. Nishimura; Y. Shimada; G. Watanabe; T. Kitano; A. Misawa; H. Ishiguro; K. Yoshikawa; K. Yanagihara; S. Teramukai; M. Mitsumori; T. Chiba; Y. Sakai; M. Fukushima Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer. Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer. Retrospective analysis of 27 consecutive patients treated with docetaxel/nedaplatin combination therapy as a second-line regimen for advanced esophageal cancer International journal of clinical oncology, 12, 3, 224-227 International journal of clinical oncology, 12, 3, 224-227 International Journal of Clinical Oncology, 12, 3, 224-227 2007/06 英語 公開
KITANO Toshiyuki, TADA Harue, NISHIMURA Tsutomu, TERAMUKAI Satoshi, KANAI Masashi, NISHIMURA Takafumi, MISAWA Akiko, YOSHIKAWA Kiyotsugu, YASUDA Hiroyasu, ISHIGURO Hiroshi, MATSUMOTO Shigemi, YANAGIHARA Kazuhiro, FUKUSHIMA Masanori KITANO Toshiyuki, TADA Harue, NISHIMURA Tsutomu, TERAMUKAI Satoshi, KANAI Masashi, NISHIMURA Takafumi, MISAWA Akiko, YOSHIKAWA Kiyotsugu, YASUDA Hiroyasu, ISHIGURO Hiroshi, MATSUMOTO Shigemi, YANAGIHARA Kazuhiro, FUKUSHIMA Masanori KITANO Toshiyuki, TADA Harue, NISHIMURA Tsutomu, TERAMUKAI Satoshi, KANAI Masashi, NISHIMURA Takafumi, MISAWA Akiko, YOSHIKAWA Kiyotsugu, YASUDA Hiroyasu, ISHIGURO Hiroshi, MATSUMOTO Shigemi, YANAGIHARA Kazuhiro, FUKUSHIMA Masanori Prevalence and Incidence of Anemia in Japanese Cancer Patients Receiving Outpatient Chemotherapy Prevalence and Incidence of Anemia in Japanese Cancer Patients Receiving Outpatient Chemotherapy Prevalence and Incidence of Anemia in Japanese Cancer Patients Receiving Outpatient Chemotherapy International journal of hematology, 86, 1, 37-41 International journal of hematology, 86, 1, 37-41 Int J Hematol, 86, 1, 37-41 2007/01/15 英語 公開
Ito T, Tanaka E, Kadowaki T, Kan T, Higashiyama M, Shiojima S, Tomoda S, Myoumoto A, Akiyama H, Nobumasa H, Matsumoto S, Miyamoto S, Mitsumori M, Sato F, Watanabe G, Itami A, Meltzer SJ, Tsujimoto G, Shimada Y Ito T, Tanaka E, Kadowaki T, Kan T, Higashiyama M, Shiojima S, Tomoda S, Myoumoto A, Akiyama H, Nobumasa H, Matsumoto S, Miyamoto S, Mitsumori M, Sato F, Watanabe G, Itami A, Meltzer SJ, Tsujimoto G, Shimada Y T. Ito; E. Tanaka; T. Kadowaki; T. Kan; M. Higashiyama; S. Shiojima; S. Tomoda; A. Myoumoto; H. Akiyama; H. Nobumasa; S. Matsumoto; S. Miyamoto; M. Mitsumori; F. Sato; G. Watanabe; A. Itami; S.J. Meltzer; G. Tsujimoto; Y. Shimada An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification. An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification. An ultrasensitive new DNA microarray chip provides gene expression profiles for preoperative esophageal cancer biopsies without RNA amplification Oncology, 73, 5-6, 366-375 Oncology, 73, 5-6, 366-375 Oncology, 73, 5-6, 366-375 2007 英語 公開
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M T. Yamanaka; S. Matsumoto; S. Teramukai; R. Ishiwata; Y. Nagai; M. Fukushima The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer Oncology, 73, 3-4, 215-220 Oncology, 73, 3-4, 215-220 Oncology, 73, 3-4, 215-220 2007 英語 公開
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M T. Yamanaka; S. Matsumoto; S. Teramukai; R. Ishiwata; Y. Nagai; M. Fukushima Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer. Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer. Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 10, 2, 129-134 Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 10, 2, 129-134 Gastric Cancer, 10, 2, 129-134 2007 英語 公開
Satoh S, Kawashima K, Matsumoto S, Hasegawa S, Okabe H, Nomura A, Yoshibayashi H, Watanabe G, Nagayama S, Fukushima M, Sakai Y Satoh S, Kawashima K, Matsumoto S, Hasegawa S, Okabe H, Nomura A, Yoshibayashi H, Watanabe G, Nagayama S, Fukushima M, Sakai Y S. Satoh; K. Kawashima; S. Matsumoto; S. Hasegawa; H. Okabe; A. Nomura; H. Yoshibayashi; G. Watanabe; S. Nagayama; M. Fukushima; Y. Sakai Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer. Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer. Retrospective evaluation of sequential outpatient chemotherapy for advanced gastric cancer Chemotherapy, 53, 3, 226-232 Chemotherapy, 53, 3, 226-232 Chemotherapy, 53, 3, 226-232 2007 英語 公開
嶋田 裕, 松本 繁巳, 森田 周子 嶋田 裕, 松本 繁巳, 森田 周子 嶋田 裕, 松本 繁巳, 森田 周子 食道の腫瘍性疾患 胸部早期食道癌 (腫瘍外科治療の最前線) -- (腫瘍外科の最新治療指針) 食道の腫瘍性疾患 胸部早期食道癌 (腫瘍外科治療の最前線) -- (腫瘍外科の最新治療指針) Early thoracic esophageal cancer 外科治療, 96, 0, 399-405 外科治療, 96, 0, 399-405 外科治療, 96, 0, 399-405 2007 日本語 公開
寺田 智祐, 尾上 雅英, 小林 政彦, 松本 繁巳, 柳原 一広, 福島 雅典, 乾 賢一 寺田 智祐, 尾上 雅英, 小林 政彦, 松本 繁巳, 柳原 一広, 福島 雅典, 乾 賢一 Terada Tomohiro, Onoue Masahide, Kobayashi Masahiko, Matsumoto Shigemi, Yanagihara Kazuhiro, Fukushima Masanori, Inui Ken-ichi 新たな薬剤師業務展開としてのUGT1A1遺伝子多型解析―簡便かつ安価な方法論の確立―:-簡便かつ安価な方法論の確立- 新たな薬剤師業務展開としてのUGT1A1遺伝子多型解析―簡便かつ安価な方法論の確立―:-簡便かつ安価な方法論の確立- Development of Gene Polymorphism Analysis System for UGT1A1 with Aim of Providing New Pharmaceutical Service-Establishment of Simple and Low-priced Methodology-:-Establishment of Simple and Low-priced Methodology- 医療薬学, 33, 10, 858-862 医療薬学, 33, 10, 858-862 Japanese Journal of Hospital Pharmacy, 33, 10, 858-862 2007 日本語 公開
Kiba T, Nishimura T, Matsumoto S, Hatano E, Mori A, Yasumi S, Doi R, Ikai I, Kitano T, Nishimura T, Yoshikawa K, Ishiguro H, Yanagihara K, Doi E, Teramukai S, Fukushima M Kiba T, Nishimura T, Matsumoto S, Hatano E, Mori A, Yasumi S, Doi R, Ikai I, Kitano T, Nishimura T, Yoshikawa K, Ishiguro H, Yanagihara K, Doi E, Teramukai S, Fukushima M Kiba T, Nishimura T, Matsumoto S, Hatano E, Mori A, Yasumi S, Doi R, Ikai I, Kitano T, Nishimura T, Yoshikawa K, Ishiguro H, Yanagihara K, Doi E, Teramukai S, Fukushima M Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature. Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature. Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature. Oncology, 70, 5, 358-365 Oncology, 70, 5, 358-365 Oncology, 70, 5, 358-365 2006 公開
S. Hasegawa; S. Matsumoto; K. Kawashima; H. Fujii; E. Hatano; S. Satoh; I. Ikai; Y. Shimahara S. Hasegawa; S. Matsumoto; K. Kawashima; H. Fujii; E. Hatano; S. Satoh; I. Ikai; Y. Shimahara Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer Combined chemotherapy with oral leucovorin (LV) + tegafur/uracil (UFT) and hepatic arterial infusion (HAI) therapy for liver metastasis of colorectal cancer Gan to kagaku ryoho. Cancer & chemotherapy, 32, 7, 1045-1049 Gan to kagaku ryoho. Cancer & chemotherapy, 32, 7, 1045-1049 , 32, 7, 1045-1049 2005 日本語 公開
YAZUMI SHUJIRO, TAKAHASHI REI, KAJIYAMA TORU, NAKASE HIROSHI, WATANABE NORIHIKO, OHANA MASAYA, MATSUMOTO SHIGEMI, SENO HIROSHI, SAWADA MITSUTAKA, UCHIDA KAZUSHIGE, NABESHIMA MOTOSHIGE, OKAZAKI KAZUICHI, CHIBA TSUTOMU YAZUMI SHUJIRO, TAKAHASHI REI, KAJIYAMA TORU, NAKASE HIROSHI, WATANABE NORIHIKO, OHANA MASAYA, MATSUMOTO SHIGEMI, SENO HIROSHI, SAWADA MITSUTAKA, UCHIDA KAZUSHIGE, NABESHIMA MOTOSHIGE, OKAZAKI KAZUICHI, CHIBA TSUTOMU YAZUMI SHUJIRO, TAKAHASHI REI, KAJIYAMA TORU, NAKASE HIROSHI, WATANABE NORIHIKO, OHANA MASAYA, MATSUMOTO SHIGEMI, SENO HIROSHI, SAWADA MITSUTAKA, UCHIDA KAZUSHIGE, NABESHIMA MOTOSHIGE, OKAZAKI KAZUICHI, CHIBA TSUTOMU COMPARISON OF HISTOLOGICAL ANALYSIS AND ENDOSONOGRAPHIC FEATURES IN ESOPHAGEAL GRANULAR CELL TUMORS COMPARISON OF HISTOLOGICAL ANALYSIS AND ENDOSONOGRAPHIC FEATURES IN ESOPHAGEAL GRANULAR CELL TUMORS COMPARISON OF HISTOLOGICAL ANALYSIS AND ENDOSONOGRAPHIC FEATURES IN ESOPHAGEAL GRANULAR CELL TUMORS Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 15, 4, 284-288 Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 15, 4, 284-288 Digestive Endoscopy, 15, 4, 284-288 2003/10/01 英語 公開
INAGAWA SATOSHI, HORI MASAO, SHIMAZAKI JIRO, MATSUMOTO SHIGEMI, ISHII HIROSHI, ITABASHI MASAYUKI, ADACHI SHINYA, KAWAMOTO TORU, FUKAO KATASHI INAGAWA SATOSHI, HORI MASAO, SHIMAZAKI JIRO, MATSUMOTO SHIGEMI, ISHII HIROSHI, ITABASHI MASAYUKI, ADACHI SHINYA, KAWAMOTO TORU, FUKAO KATASHI INAGAWA SATOSHI, HORI MASAO, SHIMAZAKI JIRO, MATSUMOTO SHIGEMI, ISHII HIROSHI, ITABASHI MASAYUKI, ADACHI SHINYA, KAWAMOTO TORU, FUKAO KATASHI Solitary Schwannoma of the Colon : Report of Two Cases Solitary Schwannoma of the Colon : Report of Two Cases Solitary Schwannoma of the Colon : Report of Two Cases Surgery today : the Japanese journal of surgery, 31, 9, 833-838 Surgery today : the Japanese journal of surgery, 31, 9, 833-838 Surg Today, 31, 9, 833-838 2001/09/01 英語 公開
MIYAMOTO SHIN-ICHI, BOKU NARIKAZU, FUJII TAKAHIRO, OHTSU ATSUSHI, MATSUMOTO SHIGEMI, TAJIRI HISAO, YOSHIDA SHIGEAKI, ARAI TATSUO, ONO MASATO, HASEBE TAKAHIRO, OCHIAI ATSUSHI MIYAMOTO SHIN-ICHI, BOKU NARIKAZU, FUJII TAKAHIRO, OHTSU ATSUSHI, MATSUMOTO SHIGEMI, TAJIRI HISAO, YOSHIDA SHIGEAKI, ARAI TATSUO, ONO MASATO, HASEBE TAKAHIRO, OCHIAI ATSUSHI MIYAMOTO SHIN-ICHI, BOKU NARIKAZU, FUJII TAKAHIRO, OHTSU ATSUSHI, MATSUMOTO SHIGEMI, TAJIRI HISAO, YOSHIDA SHIGEAKI, ARAI TATSUO, ONO MASATO, HASEBE TAKAHIRO, OCHIAI ATSUSHI Macroscopic typing with wall stricture sign may reflect tumor behaviors of advanced colorectal cancers Macroscopic typing with wall stricture sign may reflect tumor behaviors of advanced colorectal cancers Macroscopic typing with wall stricture sign may reflect tumor behaviors of advanced colorectal cancers Journal of gastroenterology, 36, 3, 158-165 Journal of gastroenterology, 36, 3, 158-165 Journal of gastroenterology, 36, 3, 158-165 2001/03/01 英語 公開
清水 伸一, 井之上 竜一, 松本 繁巳, 山口 彰則, 藤盛 孝博, 那須 正道, 千原 和夫, 出射 由香, 朝原 正京, 千葉 勉 清水 伸一, 井之上 竜一, 松本 繁巳, 山口 彰則, 藤盛 孝博, 那須 正道, 千原 和夫, 出射 由香, 朝原 正京, 千葉 勉 SHIMIZU Shin-ichi, INOUE Ryuichi, MATSUMOTO Shigemi, YAMAGUCHI Akinori, FUJIMORI Takahiro, NASU Masamichi, CHIHARA Kazuo, IDEI Yuka, ASAHARA Masakyo, CHIBA Tsutomu 地方第一線病院における緊急大腸内視鏡検査の臨床的検討 地方第一線病院における緊急大腸内視鏡検査の臨床的検討 Clinical Study of Emergency Colonoscopy in the Local Primary Hospital. 日本消化器内視鏡学会雑誌 = Gastroenterological endoscopy, 37, 5, 965-973 日本消化器内視鏡学会雑誌 = Gastroenterological endoscopy, 37, 5, 965-973 Gastroenterol Endosc, 37, 5, 965-973 1995/05/20 日本語 公開
清水 伸一, 山口 彰則, 那須 正道, 松本 繁巳, 埴岡 啓介, 藤盛 孝博, 出射 由香, 千葉 勉, 千原 和夫 清水 伸一, 山口 彰則, 那須 正道, 松本 繁巳, 埴岡 啓介, 藤盛 孝博, 出射 由香, 千葉 勉, 千原 和夫 SHIMIZU Shin-ichi, YAMAGUCHI Akinori, NASU Masamichi, MATSUMOTO Shigemi, HANIOKA Keisuke, FUJIMORI Takahiro, IDEI Yuka, CHIBA Tsutomu, CHIHARA Kazuo SLEにみられた大腸潰瘍よりの出血に対しクリップにより縫縮止血しえた1例 SLEにみられた大腸潰瘍よりの出血に対しクリップにより縫縮止血しえた1例 ENDOSCOPIC HEMOSTASIS USING THE CLIPPING APPARATUS AGAINST MASSIVE HEMORRHAGE FROM THE COLONIC ULCER DUE TO LUPUS VASCULITIS : REPORT OF A CASE 日本消化器内視鏡学会雑誌, 36, 2, 397-403_1 日本消化器内視鏡学会雑誌, 36, 2, 397-403_1 Gastroenterological Endoscopy, 36, 2, 397-403_1 1994 その他外国語 公開
那須 正道, 松本 繁巳, 朝原 正京, 山口 彰則, 清水 伸一, 藤盛 孝博, 前田 盛, 千原 和夫, 出射 由香, 千葉 勉 那須 正道, 松本 繁巳, 朝原 正京, 山口 彰則, 清水 伸一, 藤盛 孝博, 前田 盛, 千原 和夫, 出射 由香, 千葉 勉 NASU Masamichi, MATSUMOTO Shigemi, ASAHARA Masakyo, YAMAGUCHI Akinori, SHIMIZU Shin-ichi, FUJIMORI Takahiro, MAEDA Sakan, CHIHARA Kazuo, IDEI Yuka, CHIBA Tsutomu ミエロパシーで発症し,癌抑制遺伝子p53の点突然変異が証明された若年者直腸癌の1例 ミエロパシーで発症し,癌抑制遺伝子p53の点突然変異が証明された若年者直腸癌の1例 A case of a juvenile rectal cancer with point mutation of tumor suppressor p53 gene manifesting myelopathy as an initial symptom. 日本消化機病學會雜誌. 乙, 91, 7, 1241-1246 日本消化機病學會雜誌. 乙, 91, 7, 1241-1246 Nippon Shokakibyo Gakkai Zasshi, 91, 7, 1241-1246 1994 日本語 公開
Nomura M, Otsuka A, Yoshimura M, Nonomura Y, Kaku Y, Matsumoto S, Muto M Nomura M, Otsuka A, Yoshimura M, Nonomura Y, Kaku Y, Matsumoto S, Muto M Efficacy and safety of concurrent immunoradiotherapy in patients with metastatic melanoma after progression on nivolumab. Efficacy and safety of concurrent immunoradiotherapy in patients with metastatic melanoma after progression on nivolumab. Cancer chemotherapy and pharmacology, 81, 5, 823-827 , 81, 5, 823-827 Cancer chemotherapy and pharmacology, 81, 5, 823-827 2018/05 公開
Kondo T, Kanai M, Kou T, Sakuma T, Mochizuki H, Kamada M, Nakatsui M, Uza N, Kodama Y, Masui T, Takaori K, Matsumoto S, Miyake H, Okuno Y, Muto M Kondo T, Kanai M, Kou T, Sakuma T, Mochizuki H, Kamada M, Nakatsui M, Uza N, Kodama Y, Masui T, Takaori K, Matsumoto S, Miyake H, Okuno Y, Muto M Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer. Oncotarget, 9, 28, 19817-19825 , 9, 28, 19817-19825 Oncotarget, 9, 28, 19817-19825 2018/04 公開
Masui T, Takaori K, Anazawa T, Sato A, Nakano K, Uchida Y, Yogo A, Goto Y, Matsumoto S, Kodama Y, Kanai M, Isoda H, Mizumoto M, Kawaguchi Y, Shibuya K, Itasaka S, Uemoto S Masui T, Takaori K, Anazawa T, Sato A, Nakano K, Uchida Y, Yogo A, Goto Y, Matsumoto S, Kodama Y, Kanai M, Isoda H, Mizumoto M, Kawaguchi Y, Shibuya K, Itasaka S, Uemoto S A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Cancer Patients with Arterial Involvement. A Prospective Study of Intensity-modified Radiation Therapy in Comparison with Conventional 3D-RT for BR Pancreatic Cancer Patients with Arterial Involvement. Anticancer research, 37, 12, 7023-7030 , 37, 12, 7023-7030 Anticancer research, 37, 12, 7023-7030 2017/12 公開
Ohkawa S, Okusaka T, Isayama H, Fukutomi A, Yamaguchi K, Ikeda M, Funakoshi A, Nagase M, Hamamoto Y, Nakamori S, Tsuchiya Y, Baba H, Ishii H, Omuro Y, Sho M, Matsumoto S, Yamada N, Yanagimoto H, Unno M, Ichikawa Y, Takahashi S, Watanabe G, Wakabayashi G, Egawa N, Tsuda M, Hosotani R, Hamada C, Hyodo I Ohkawa S, Okusaka T, Isayama H, Fukutomi A, Yamaguchi K, Ikeda M, Funakoshi A, Nagase M, Hamamoto Y, Nakamori S, Tsuchiya Y, Baba H, Ishii H, Omuro Y, Sho M, Matsumoto S, Yamada N, Yanagimoto H, Unno M, Ichikawa Y, Takahashi S, Watanabe G, Wakabayashi G, Egawa N, Tsuda M, Hosotani R, Hamada C, Hyodo I Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer. Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer. British journal of cancer, 112, 9, 1428-1434 , 112, 9, 1428-1434 British journal of cancer, 112, 9, 1428-1434 2015/04 公開
M. Kanai; Y. Otsuka; K. Otsuka; M. Sato; T. Nishimura; Y. Mori; M. Kawaguchi; E. Hatano; Y. Kodama; S. Matsumoto; Y. Murakami; A. Imaizumi; T. Chiba; J. Nishihira; H. Shibata M. Kanai; Y. Otsuka; K. Otsuka; M. Sato; T. Nishimura; Y. Mori; M. Kawaguchi; E. Hatano; Y. Kodama; S. Matsumoto; Y. Murakami; A. Imaizumi; T. Chiba; J. Nishihira; H. Shibata A phase i study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients A phase i study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients Cancer Chemotherapy and Pharmacology, 71, 6, 1521-1530 , 71, 6, 1521-1530 Cancer Chemotherapy and Pharmacology, 71, 6, 1521-1530 2013 英語 公開
M. Kanai; A. Imaizumi; Y. Otsuka; H. Sasaki; M. Hashiguchi; K. Tsujiko; S. Matsumoto; H. Ishiguro; T. Chiba M. Kanai; A. Imaizumi; Y. Otsuka; H. Sasaki; M. Hashiguchi; K. Tsujiko; S. Matsumoto; H. Ishiguro; T. Chiba Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers Cancer Chemotherapy and Pharmacology, 69, 1, 65-70 , 69, 1, 65-70 Cancer Chemotherapy and Pharmacology, 69, 1, 65-70 2012 英語 公開
M. Kanai; K. Yoshimura; M. Asada; A. Imaizumi; C. Suzuki; S. Matsumoto; T. Nishimura; Y. Mori; T. Masui; Y. Kawaguchi; K. Yanagihara; S. Yazumi; T. Chiba; S. Guha; B.B. Aggarwal M. Kanai; K. Yoshimura; M. Asada; A. Imaizumi; C. Suzuki; S. Matsumoto; T. Nishimura; Y. Mori; T. Masui; Y. Kawaguchi; K. Yanagihara; S. Yazumi; T. Chiba; S. Guha; B.B. Aggarwal A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer Cancer Chemotherapy and Pharmacology, 68, 1, 157-164 , 68, 1, 157-164 Cancer Chemotherapy and Pharmacology, 68, 1, 157-164 2011/07 英語 公開
M. Kanai; K. Yoshimura; T. Tsumura; M. Asada; C. Suzuki; M. Niimi; S. Matsumoto; T. Nishimura; T. Nitta; K. Yasuchika; K. Taura; Y. Mori; A. Hamada; N. Inoue; S. Tada; K. Yanagihara; S. Yazumi; Y. Osaki; T. Chiba; I. Ikai; M. Fukushima; S. Uemoto; E. Hatano M. Kanai; K. Yoshimura; T. Tsumura; M. Asada; C. Suzuki; M. Niimi; S. Matsumoto; T. Nishimura; T. Nitta; K. Yasuchika; K. Taura; Y. Mori; A. Hamada; N. Inoue; S. Tada; K. Yanagihara; S. Yazumi; Y. Osaki; T. Chiba; I. Ikai; M. Fukushima; S. Uemoto; E. Hatano A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer Cancer Chemotherapy and Pharmacology, 67, 6, 1429-1434 , 67, 6, 1429-1434 Cancer Chemotherapy and Pharmacology, 67, 6, 1429-1434 2011/06 英語 公開
C. Zaima; M. Kanai; S. Ishikawa; Y. Kawaguchi; T. Masui; Y. Mori; T. Nishimura; S. Matsumoto; K. Yanagihara; T. Chiba; T. Mimori C. Zaima; M. Kanai; S. Ishikawa; Y. Kawaguchi; T. Masui; Y. Mori; T. Nishimura; S. Matsumoto; K. Yanagihara; T. Chiba; T. Mimori A Case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis A Case of progressive digital ischemia after early withdrawal of gemcitabine and S-1 in a patient with systemic sclerosis Japanese Journal of Clinical Oncology, 41, 6, 803-806 , 41, 6, 803-806 Japanese Journal of Clinical Oncology, 41, 6, 803-806 2011/06 英語 公開
A.A. Alaboudy; A. Elbahrawy; S. Matsumoto; A. Yoshizawa A.A. Alaboudy; A. Elbahrawy; S. Matsumoto; A. Yoshizawa Conventional narrow-band imaging has good correlation with histopathological severity of Helicobacter pylori gastritis Conventional narrow-band imaging has good correlation with histopathological severity of Helicobacter pylori gastritis Digestive Diseases and Sciences, 56, 4, 1127-1130 , 56, 4, 1127-1130 Digestive Diseases and Sciences, 56, 4, 1127-1130 2011 英語 公開
M. Minami; S. Matsumoto; H. Horiuchi M. Minami; S. Matsumoto; H. Horiuchi Cardiovascular side-effects of modern cancer therapy Cardiovascular side-effects of modern cancer therapy Circulation Journal, 74, 9, 1779-1786 , 74, 9, 1779-1786 Circulation Journal, 74, 9, 1779-1786 2010/09 英語 公開
M. Kanai; A. Yoshioka; S. Tanaka; S. Nagayama; S. Matsumoto; T. Nishimura; M. Niimi; S. Teramukai; R. Takahashi; Y. Mori; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba; M. Fukushima; F. Matsuda M. Kanai; A. Yoshioka; S. Tanaka; S. Nagayama; S. Matsumoto; T. Nishimura; M. Niimi; S. Teramukai; R. Takahashi; Y. Mori; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba; M. Fukushima; F. Matsuda Associations between glutathione S-transferase π Ile<sup>105</sup>Val and glyoxylate aminotransferase Pro<sup>11</sup>Leu and Ile<sup>340</sup>Met polymorphisms and early-onset oxaliplatin-induced neuropathy Associations between glutathione S-transferase π Ile<sup>105</sup>Val and glyoxylate aminotransferase Pro<sup>11</sup>Leu and Ile<sup>340</sup>Met polymorphisms and early-onset oxaliplatin-induced neuropathy Cancer Epidemiology, 34, 2, 189-193 , 34, 2, 189-193 Cancer Epidemiology, 34, 2, 189-193 2010/04 英語 公開
M. Kanai; S. Matsumoto; T. Nishimura; Y. Matsumura; E. Hatano; A. Mori; T. Masui; Y. Kawaguchi; E. Nakamura; S. Tada; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba M. Kanai; S. Matsumoto; T. Nishimura; Y. Matsumura; E. Hatano; A. Mori; T. Masui; Y. Kawaguchi; E. Nakamura; S. Tada; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy. Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 21, 1, 189-190 , 21, 1, 189-190 Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 21, 1, 189-190 2010 英語 公開
M. Kanai; S. Morita; S. Matsumoto; T. Nishimura; E. Hatano; S. Yazumi; T. Sasaki; H. Yasuda; T. Kitano; A. Misawa; H. Ishiguro; K. Yanagihara; I. Ikai; R. Doi; M. Fukushima M. Kanai; S. Morita; S. Matsumoto; T. Nishimura; E. Hatano; S. Yazumi; T. Sasaki; H. Yasuda; T. Kitano; A. Misawa; H. Ishiguro; K. Yanagihara; I. Ikai; R. Doi; M. Fukushima A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia Annals of Oncology, 20, 8, 1397-1401 , 20, 8, 1397-1401 Annals of Oncology, 20, 8, 1397-1401 2009/08 英語 公開
M. Onoue; T. Terada; M. Kobayashi; T. Katsura; S. Matsumoto; K. Yanagihara; T. Nishimura; M. Kanai; S. Teramukai; A. Shimizu; M. Fukushima; K.-I. Inui M. Onoue; T. Terada; M. Kobayashi; T. Katsura; S. Matsumoto; K. Yanagihara; T. Nishimura; M. Kanai; S. Teramukai; A. Shimizu; M. Fukushima; K.-I. Inui UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients International Journal of Clinical Oncology, 14, 2, 136-142 , 14, 2, 136-142 International Journal of Clinical Oncology, 14, 2, 136-142 2009/04 英語 公開
S. Morita; S. Miyamoto; S. Matsumoto; M. Muto; T. Chiba S. Morita; S. Miyamoto; S. Matsumoto; M. Muto; T. Chiba Multiple early-stage malignant melanoma of the esophagus with long follow-up period after endoscopic treatment: Report of a case Multiple early-stage malignant melanoma of the esophagus with long follow-up period after endoscopic treatment: Report of a case Esophagus, 6, 4, 249-252 , 6, 4, 249-252 Esophagus, 6, 4, 249-252 2009 英語 公開
M. Kanai; S. Matsumoto; T. Nishimura; Y. Matsumura; E. Hatano; A. Mori; T. Masui; Y. Kawaguchi; E. Nakamura; S. Tada; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba M. Kanai; S. Matsumoto; T. Nishimura; Y. Matsumura; E. Hatano; A. Mori; T. Masui; Y. Kawaguchi; E. Nakamura; S. Tada; T. Kitano; H. Ishiguro; K. Yanagihara; T. Chiba Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy Annals of Oncology, 21, 1, 189-190 , 21, 1, 189-190 Annals of Oncology, 21, 1, 189-190 2009 英語 公開
K. Yamamoto; S. Matsumoto; H. Tada; K. Yanagihara; S. Teramukai; T. Takemura; M. Fukushima K. Yamamoto; S. Matsumoto; H. Tada; K. Yanagihara; S. Teramukai; T. Takemura; M. Fukushima A data capture system for outcomes studies that integrates with electronic health records: Development and potential uses A data capture system for outcomes studies that integrates with electronic health records: Development and potential uses Journal of Medical Systems, 32, 5, 423-427 , 32, 5, 423-427 Journal of Medical Systems, 32, 5, 423-427 2008/10 英語 公開
T. Yamanaka; S. Matsumoto; S. Teramukai; R. Ishiwata; Y. Nagai; M. Fukushima T. Yamanaka; S. Matsumoto; S. Teramukai; R. Ishiwata; Y. Nagai; M. Fukushima Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma British Journal of Cancer, 97, 1, 37-42 , 97, 1, 37-42 British Journal of Cancer, 97, 1, 37-42 2007 英語 公開
S. Ohashi; S. Yazumi; N. Watanabe; S. Matsumoto; T. Fukui; A. Nishio; T. Chiba S. Ohashi; S. Yazumi; N. Watanabe; S. Matsumoto; T. Fukui; A. Nishio; T. Chiba Gastrointestinal: MALT lymphoma of the terminal ileum Gastrointestinal: MALT lymphoma of the terminal ileum Journal of Gastroenterology and Hepatology (Australia), 21, 9, 1495- , 21, 9, 1495- Journal of Gastroenterology and Hepatology (Australia), 21, 9, 1495- 2006 英語 公開
S. Yazumi; R. Takahashi; T. Kajiyama; H. Nakase; N. Watanabe; M. Ohana; S. Matsumoto; H. Seno; M. Sawada; K. Uchida; M. Nabeshima; K. Okazaki; T. Chiba S. Yazumi; R. Takahashi; T. Kajiyama; H. Nakase; N. Watanabe; M. Ohana; S. Matsumoto; H. Seno; M. Sawada; K. Uchida; M. Nabeshima; K. Okazaki; T. Chiba Comparison of histological analysis and endosonographic features in esophageal granular cell tumors Comparison of histological analysis and endosonographic features in esophageal granular cell tumors Digestive Endoscopy, 15, 4, 284-288 , 15, 4, 284-288 Digestive Endoscopy, 15, 4, 284-288 2003 英語 公開
N. Watanabe; H. Seno; T. Nakajima; S. Yazumi; S. Miyamoto; S. Matsumoto; T. Itoh; C. Kawanami; K. Okazaki; T. Chiba N. Watanabe; H. Seno; T. Nakajima; S. Yazumi; S. Miyamoto; S. Matsumoto; T. Itoh; C. Kawanami; K. Okazaki; T. Chiba Regression of fundic gland polyps following acquisition of Helicobacter pylori Regression of fundic gland polyps following acquisition of Helicobacter pylori Gut, 51, 5, 742-745 , 51, 5, 742-745 Gut, 51, 5, 742-745 2002 英語 公開
Tajiri H, Ohtsu A, Boku N, Muto M, Chin K, Matsumoto S, Yoshida S Tajiri H, Ohtsu A, Boku N, Muto M, Chin K, Matsumoto S, Yoshida S Routine endoscopy using electronic endoscopes for gastric cancer diagnosis: retrospective study of inconsistencies between endoscopic and biopsy diagnoses. Routine endoscopy using electronic endoscopes for gastric cancer diagnosis: retrospective study of inconsistencies between endoscopic and biopsy diagnoses. Cancer detection and prevention, 25, 2, 166-173 , 25, 2, 166-173 Cancer detection and prevention, 25, 2, 166-173 2001 公開
S.-I. Miyamoto; N. Boku; T. Fujii; A. Ohtsu; S. Matsumoto; H. Tajiri; S. Yoshida; T. Arai; M. Ono; T. Hasebe; A. Ochiai S.-I. Miyamoto; N. Boku; T. Fujii; A. Ohtsu; S. Matsumoto; H. Tajiri; S. Yoshida; T. Arai; M. Ono; T. Hasebe; A. Ochiai Macroscopic typing with wall stricture sign may reflect tumor behaviors of advanced colorectal cancers Macroscopic typing with wall stricture sign may reflect tumor behaviors of advanced colorectal cancers Journal of Gastroenterology, 36, 3, 158-165 , 36, 3, 158-165 Journal of Gastroenterology, 36, 3, 158-165 2001 英語 公開
T. Nomura; N. Boku; A. Ohtsu; M. Muto; S. Matsumoto; H. Tajiri; S. Yoshida T. Nomura; N. Boku; A. Ohtsu; M. Muto; S. Matsumoto; H. Tajiri; S. Yoshida Recurrence after endoscopic mucosal resection for superficial esophageal cancer Recurrence after endoscopic mucosal resection for superficial esophageal cancer Endoscopy, 32, 4, 277-280 , 32, 4, 277-280 Endoscopy, 32, 4, 277-280 2000/04 英語 公開
T. Maekawa; Y. Kinoshita; H. Fukui; S. Matsumoto; S. Hirota; K. Chihara; T. Fujimori; T. Chiba T. Maekawa; Y. Kinoshita; H. Fukui; S. Matsumoto; S. Hirota; K. Chihara; T. Fujimori; T. Chiba Reciprocal changes in progression of gastric mucosa-associated lymphoid tissue lymphoma and pancreatic somatostatinoma Reciprocal changes in progression of gastric mucosa-associated lymphoid tissue lymphoma and pancreatic somatostatinoma American Journal of Medicine, 105, 6, 539-540 , 105, 6, 539-540 American Journal of Medicine, 105, 6, 539-540 1998 英語 公開
Matsumoto S, Kinoshita Y, Fukuda H, Waki S, Asahara M, Matsushima Y, Kawanami C, Fujimori T, Chiba T Matsumoto S, Kinoshita Y, Fukuda H, Waki S, Asahara M, Matsushima Y, Kawanami C, Fujimori T, Chiba T "Mediterranean lymphoma" treated with antibiotics. "Mediterranean lymphoma" treated with antibiotics. Internal medicine (Tokyo, Japan), 35, 12, 961-965 , 35, 12, 961-965 Internal medicine (Tokyo, Japan), 35, 12, 961-965 1996/12 公開

  • <<
  • >>
  • 表示
タイトル言語:
Misc
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
水本 雅己, 高折 恭一, 増井 俊彦, 川口 道也, 岩永 康裕, 板坂 聡, 南口 早智子, 松本 繁巳, 上本 伸二 水本 雅己, 高折 恭一, 増井 俊彦, 川口 道也, 岩永 康裕, 板坂 聡, 南口 早智子, 松本 繁巳, 上本 伸二 PS-017-2 局所進行膵癌に対するIMRT併用術前化学放射線療法の検討(PS-017 膵 集学的治療-1,ポスターセッション,第114回日本外科学会定期学術集会) PS-017-2 局所進行膵癌に対するIMRT併用術前化学放射線療法の検討(PS-017 膵 集学的治療-1,ポスターセッション,第114回日本外科学会定期学術集会) 日本外科学会雑誌, 115, 2 日本外科学会雑誌, 115, 2 , 115, 2 2014/03/05 日本語 公開
中田 和美, 高島 幸恵, 松本 繁巳, 柳原 一広, 三尾 直志, 亀野 薫 中田 和美, 高島 幸恵, 松本 繁巳, 柳原 一広, 三尾 直志, 亀野 薫 P-194 非小細胞肺癌治療におけるパクリタキセルによる「しびれ」に対する炭酸泉浴の効果の検討(化学療法副作用, 第47回日本肺癌学会総会) P-194 非小細胞肺癌治療におけるパクリタキセルによる「しびれ」に対する炭酸泉浴の効果の検討(化学療法副作用, 第47回日本肺癌学会総会) 肺癌, 46, 5 肺癌, 46, 5 , 46, 5 2006/11/05 日本語 公開
稲川 智, 堀 眞佐男, 島崎 二郎, 石井 洋, 松本 繁巳, 板橋 正幸 稲川 智, 堀 眞佐男, 島崎 二郎, 石井 洋, 松本 繁巳, 板橋 正幸 PP643 大腸原発schwannomaの2例 PP643 大腸原発schwannomaの2例 日本消化器外科学会雑誌, 33, 7 日本消化器外科学会雑誌, 33, 7 , 33, 7 2000/07/01 日本語 公開
松本 繁巳, 末松 正邦, 寺島 充康, 上野 洋, 竹内 素志, 井上 智夫, 山辺 裕, 川原 康洋, 横田 慶之, 石川 雄一, 横山 光宏 松本 繁巳, 末松 正邦, 寺島 充康, 上野 洋, 竹内 素志, 井上 智夫, 山辺 裕, 川原 康洋, 横田 慶之, 石川 雄一, 横山 光宏 急性心筋梗塞様心電図異常を示しPCR法にて急性心筋炎と診断された1症例 : 日本循環器学会第73回近畿地方会 急性心筋梗塞様心電図異常を示しPCR法にて急性心筋炎と診断された1症例 : 日本循環器学会第73回近畿地方会 Japanese circulation journal, 58, 0 Japanese circulation journal, 58, 0 , 58, 0 1994/04/20 日本語 公開
謝 韶銘, 中村 博文, 河本 英作, 兪 陽子, 松本 繁巳, 那須 正道, 橋本 由香子, 朝原 正京, 清水 伸一, 田口 寛, 岡田 昌義 謝 韶銘, 中村 博文, 河本 英作, 兪 陽子, 松本 繁巳, 那須 正道, 橋本 由香子, 朝原 正京, 清水 伸一, 田口 寛, 岡田 昌義 多発性の塞栓症状を契機に発見された左房粘液腫の一例 : 日本循環器学会第74回近畿地方会 多発性の塞栓症状を契機に発見された左房粘液腫の一例 : 日本循環器学会第74回近畿地方会 Japanese circulation journal, 58, 0 Japanese circulation journal, 58, 0 , 58, 0 1994/04/20 日本語 公開
タイトル言語:
講演・口頭発表等
タイトル タイトル(日本語) タイトル(英語) 会議名 会議名(日本語) 会議名(英語) 主催者 主催者(日本語) 主催者(英語) 開催年月日 記述言語 会議種別 公開
胃がん薬物療法の最前線[招待あり] 胃がん薬物療法の最前線 [招待あり] 京都府民公開講座 京都府民公開講座 2017/01/07 日本語 公開講演、セミナー、チュートリアル、講習、講義 公開
腫瘍マーカー検査〜臨床的活用法と注意点〜[招待あり] 腫瘍マーカー検査〜臨床的活用法と注意点〜 [招待あり] 京都府医師会・臨床検査技師会合同学術研修会 京都府医師会・臨床検査技師会合同学術研修会 2016/12/10 日本語 口頭発表(招待・特別) 公開
原発不明がん患者に対するクリニカルシーケンス(OncoPrimeTM)を用いたprecision medicine 原発不明がん患者に対するクリニカルシーケンス(OncoPrimeTM)を用いたprecision medicine Precision medicine for a patient with cancer of unknown primary site 日本臨床腫瘍学会 日本臨床腫瘍学会 2016/07/30 日本語 シンポジウム・ワークショップパネル(公募) 公開
がん薬物療法の最新の話題[招待あり] がん薬物療法の最新の話題 [招待あり] 京都薬科大学 卒後教育講座 京都薬科大学 卒後教育講座 2016/06/19 日本語 公開講演、セミナー、チュートリアル、講習、講義 公開
これからのがん診療とメディカルスタッフの連携[招待あり] これからのがん診療とメディカルスタッフの連携 [招待あり] 日臨技近畿支部遺伝子部門研修会 日臨技近畿支部遺伝子部門研修会 2016/01/23 日本語 公開講演、セミナー、チュートリアル、講習、講義 公開
神経内分泌腫瘍治療の最前線[招待あり] 神経内分泌腫瘍治療の最前線 [招待あり] 日本病理学会近畿支部学術集会 日本病理学会近畿支部学術集会 2015/12/12 日本語 口頭発表(招待・特別) 公開
京大がんセンターの目指すところ 京大がんセンターの目指すところ 健康科学市民公開講座 健康科学市民公開講座 2015/11/09 日本語 公開講演、セミナー、チュートリアル、講習、講義 公開
京大病院がんセンターにおける がんチーム医療研修の取り組み 京大病院がんセンターにおける がんチーム医療研修の取り組み Multidisciplinary care program in Kyoto university hospital cancer center 日本癌治療学会 日本癌治療学会 2015/10/29 日本語 ポスター発表 公開
進行再発大腸癌における経口抗がん薬の役割[招待あり] 進行再発大腸癌における経口抗がん薬の役割 [招待あり] 日本医療薬学会 日本医療薬学会 2015/09/27 日本語 口頭発表(招待・特別) 公開
日常がん診療におけるLMS (Lesion Management Solution, Median technologies) を用いた治療効果判定システムの構築 日常がん診療におけるLMS (Lesion Management Solution, Median technologies) を用いた治療効果判定システムの構築 Setting up of a new therapeutic evaluation workflow deploying LMS (Lesion Management Solution, Median technologies, France) in oncology practice 日本臨床腫瘍学会 日本臨床腫瘍学会 2015/07/16 日本語 ポスター発表 公開
How do you collect and use the clinical data from EHRs?[招待あり] How do you collect and use the clinical data from EHRs? [招待あり] How do you collect and use the clinical data from EHRs? [招待あり] Kyoto university-INSERM CRC Paris Joint Symposium Kyoto university-INSERM CRC Paris Joint Symposium Kyoto university-INSERM CRC Paris Joint Symposium 2015/06/25 英語 シンポジウム・ワークショップパネル(指名) 公開
「がん患者指導管理の充実を目指して」〜京大病院がんチーム医療研修〜[招待あり] 「がん患者指導管理の充実を目指して」〜京大病院がんチーム医療研修〜 [招待あり] 「医療の改善運動」全国大会 「医療の改善運動」全国大会 2014/11/15 日本語 口頭発表(招待・特別) 公開
京都大学における神経内分泌腫瘍への取り組み〜診断から治療まで〜[招待あり] 京都大学における神経内分泌腫瘍への取り組み〜診断から治療まで〜 [招待あり] 日本癌治療学会 日本癌治療学会 2014/08/29 日本語 口頭発表(招待・特別) 公開
京大病院がんセンターにおける原発不明癌(CUP)・希少癌ユニットの取り組み 京大病院がんセンターにおける原発不明癌(CUP)・希少癌ユニットの取り組み Unit of primary unknown cancer in Kyoto university hospital cancer center 日本臨床腫瘍学会 日本臨床腫瘍学会 2014/07/17 日本語 口頭発表(一般) 公開
「消化器癌に対する化学療法の最前線」大腸癌の化学療法[招待あり] 「消化器癌に対する化学療法の最前線」大腸癌の化学療法 [招待あり] 日本内科学会近畿地方会 日本内科学会近畿地方会 2014/03/01 日本語 公開講演、セミナー、チュートリアル、講習、講義 公開
京大がんセンターにおけるチーム医療:臨床腫瘍医の役割[招待あり] 京大がんセンターにおけるチーム医療:臨床腫瘍医の役割 [招待あり] Multidisciplinary team in Kyoto University Hospital Cancer Center: The role of oncologist. [招待あり] 日本癌治療学会 日本癌治療学会 2013/10/25 日本語 シンポジウム・ワークショップパネル(指名) 公開
大腸癌術後化学療法の現状[招待あり] 大腸癌術後化学療法の現状 [招待あり] 日本癌治療学会 日本癌治療学会 2013/10/24 日本語 シンポジウム・ワークショップパネル(指名) 公開

  • <<
  • >>
  • 表示
タイトル言語: